Search research articles
Contact Us
Filters
Showing results (141-150 of 146) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 146 results.
ERJ Open Research
|
October 1, 2024
Associations between respiratory pathogens and lung function in primary ciliary dyskinesia: cross-sectional analysis from the PROVALF-PCD cohort
Bruna Rubbo, Avni Kant, Kewei Zhang, et al.
ERJ Open Research
|
January 5, 2022
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe
Andreas Jung, Annalisa Orenti, Fiona Dunlevy, et al.
Thorax
|
July 4, 2024
Epidemiology of childhood interstitial lung disease in France: the RespiRare cohort
Camille Fletcher, Alice Hadchouel, Caroline Thumerelle, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
January 27, 2021
Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth
Yu-Chung Lin, Katherine Keenan, Jiafen Gong, et al.
The European Respiratory Journal
|
February 16, 2023
The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del <i>CFTR</i> variant
Pierre-Régis Burgel, Isabelle Sermet-Gaudelus, Isabelle Durieu, et al.
The European Respiratory Journal
|
November 19, 2021
Using chest computed tomography and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis
Alienor Campredon, Enzo Battistella, Clémence Martin, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 146) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 146 results.
ERJ Open Research
|
October 1, 2024
Associations between respiratory pathogens and lung function in primary ciliary dyskinesia: cross-sectional analysis from the PROVALF-PCD cohort
Bruna Rubbo, Avni Kant, Kewei Zhang, et al.
ERJ Open Research
|
January 5, 2022
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe
Andreas Jung, Annalisa Orenti, Fiona Dunlevy, et al.
Thorax
|
July 4, 2024
Epidemiology of childhood interstitial lung disease in France: the RespiRare cohort
Camille Fletcher, Alice Hadchouel, Caroline Thumerelle, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
January 27, 2021
Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth
Yu-Chung Lin, Katherine Keenan, Jiafen Gong, et al.
The European Respiratory Journal
|
February 16, 2023
The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del <i>CFTR</i> variant
Pierre-Régis Burgel, Isabelle Sermet-Gaudelus, Isabelle Durieu, et al.
The European Respiratory Journal
|
November 19, 2021
Using chest computed tomography and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis
Alienor Campredon, Enzo Battistella, Clémence Martin, et al.
Page
of 15